Consequently, GADD45β is highly expressed in most multiple myelomas, where it suppresses apoptosis ensuing from spontaneous JNK/MAPK-pathway activation by inhibiting the JNK kinase, MKK7 [4]. Here, GADD45B is linked to plasma cell myeloma.